ACS Editors' Choice: Taming Membrane-Disrupting Antibiotics - and More! - ACS Axial | ACS Publications

ACS Editors’ Choice: Taming Membrane-Disrupting Antibiotics — and More!

This week: nanocarriers for cancer drugs, photocarrier dynamics in solar cells, taming membrane-disrupting antibiotics — and more!

Each and every day, ACS grants free access to a new peer-reviewed research article from one of the Society’s journals. These articles are specially chosen by a team of scientific editors of ACS journals from around the world to highlight the transformative power of chemistry. Access to these articles will remain open to all as a public service.

Check out this week’s picks!
The Discovery, Preclinical, and Early Clinical Development of Potent and Selective GPR40 Agonists for the Treatment of Type 2 Diabetes Mellitus (LY2881835, LY2922083, and LY2922470)
J. Med. Chem., Article ASAP
DOI: 10.1021/acs.jmedchem.6b00892
Linear Absorption Spectra from Explicitly Time-Dependent Equation-of-Motion Coupled-Cluster Theory
J. Chem. Theory Comput., Article ASAP
DOI: 10.1021/acs.jctc.6b00796
Simple Strategy for Taming Membrane-Disrupting Antibiotics
Bioconjugate Chem., Article ASAP
DOI: 10.1021/acs.bioconjchem.6b00629
Organocatalytic Cationic Ring-Opening Polymerization of a Cyclic Hemiacetal Ester
Ind. Eng. Chem. Res., Article ASAP
DOI: 10.1021/acs.iecr.6b03114
Thermoresponsive Delivery of Paclitaxel by β-Cyclodextrin-Based Poly(N-isopropylacrylamide) Star Polymer via Inclusion Complexation
Biomacromolecules, Article ASAP
DOI: 10.1021/acs.biomac.6b01344
Amplification of the Optical Activity of Gold Clusters by the Proximity of BINAP
J. Phys. Chem. Lett., 2016, 7, pp 4509–4513
DOI: 10.1021/acs.jpclett.6b02294
Photo-Carrier Multi-Dynamical Imaging at the Nanometer Scale in Organic and Inorganic Solar Cells
ACS Appl. Mater. Interfaces, Article ASAP
DOI: 10.1021/acsami.6b11423
Love ACS Editors’ Choice? Get a weekly e-mail of the latest ACS Editor’s Choice articles and never miss a breakthrough!

Want more stories like this delivered to your inbox?

Sign up for our newsletter to receive a selection of stories related to your favorite topics.

  • This field is for validation purposes and should be left unchanged.